Your browser doesn't support javascript.
loading
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
Feijen, Elizabeth A M; Leisenring, Wendy M; Stratton, Kayla L; Ness, Kirsten K; van der Pal, Helena J H; van Dalen, Elvira C; Armstrong, Gregory T; Aune, Gregory J; Green, Daniel M; Hudson, Melissa M; Loonen, Jacqueline; Oeffinger, Kevin C; Robison, Leslie L; Yasui, Yutaka; Kremer, Leontien C M; Chow, Eric J.
Affiliation
  • Feijen EAM; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Leisenring WM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Stratton KL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Ness KK; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • van der Pal HJH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • van Dalen EC; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Aune GJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Green DM; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Hudson MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Loonen J; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Oeffinger KC; Department of Pediatrics, Greehey Children's Cancer Research Institute, The University of Texas Health Science Center at San Antonio.
  • Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Yasui Y; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Kremer LCM; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Chow EJ; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
JAMA Oncol ; 5(6): 864-871, 2019 Jun 01.
Article in En | MEDLINE | ID: mdl-30703192

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Anthracyclines / Cardiotoxicity / Cancer Survivors / Antibiotics, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: JAMA Oncol Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Anthracyclines / Cardiotoxicity / Cancer Survivors / Antibiotics, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: JAMA Oncol Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United States